Infections related to prosthetic materials in patients on chronic dialysis

Clinical Microbiology and Infection

Volumn 8, Issue 11, 2002, Pages 705-708

  Vas, S I ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; DIALYSIS FLUID; METICILLIN; POLITEF; PSEUDOMONIC ACID; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTERIOVENOUS FISTULA; ARTICLE; AUTOMATION; BIOFILM; BLOOD VESSEL CATHETERIZATION; DIAGNOSTIC PROCEDURE; DIALYSIS; DOSE RESPONSE; DRUG INDICATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MATERIAL COATING; NONHUMAN; PENICILLIN RESISTANCE; PERITONEAL DIALYSIS; PERITONITIS; POLITEF IMPLANT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHESIS MATERIAL; PSEUDOMONAS;

PSEUDOMONAS;

EID: 0036854581     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00491.x     Document Type: Article

References (33)

1. Schaubel DE, Morrison HI, Desmeules M, Parsons D, Fenton SS. End-stage renal disease projections for Canada to 2005a using Poisson and Markov models. Int J Epidemiol 1998; 27: 274-81.
2. Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2001; 22: 222-42.
3. Keane WF, Bailie GR, Boeschoten E et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 2000; 20: 396-411.
4. Tokars JI, Arduino MJ, Alter MJ. Infection control in hemodialysis units. Infect Dis Clin North Am 2001; 15: 797-812.
5. Donlan RM. Biofilms. Clin Infect Dis 2001; 33: 1387-92.
6. Darouiche RO. Device-associated infections and adherence. Clin Infect Dis 2001; 33: 1567-72.
7. Pai MP, Pendland SL, Danziger LH. Antimicrobial-coated/ bonded and -impregnated intravascular catheters. Ann Pharmacother 2001; 35: 1255-63.
8. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J 2000; 46: 547-52.
9. Lew SQ, Kaveh K. Dialysis access related infections. ASIO J 2000; 46: S6-S12.
10. http://www.kidney.org/professionals/doqi/.
11. Jean G, Charra B, Chazot C, Vanel T, Terrat JC, Hurot JM. Long-term outcome of permanent hemodialysis catheters: a controlled study. Blood Purif 2001; 19: 401-7.
12. Farr BM. Prevention of catheter-related infections. Clin Infect Dis 2001; 33: 1733-8.
13. Carlisle EJ, Blake P, McCarthy F, Vas S, Uldall R. Septicemia in long-term jugular hemodialysis catheters; eradicating infection by changing the catheter over a guidewire. Int J Artif Organs 1991; 14: 150-3.
14. Beathard GA, Posen GA. Initial clinical results with the LifeSite Hemodialysis Access System. Kidney Int 2000; 58: 2221-7.
15. Canaud B, My H, Morena M et al. Dialock: a new vascular access device for extracorporeal renal replacement therapy. Preliminary clinical results. Nephrol Dial Transplant 1999; 14: 692-8.
16. Nissenson AR. Daily hemodialysis: Challenges and opportunities in the delivery and financing of endstage renal disease patient care. Adv Ren Replace Ther 2001; 8: 286-90.
17. Lockridge RS Jr, Spencer M, Craft V et al. Nocturnal home hemodialysis in North America. Adv Ren Replace Ther 2001; 8: 250-6.
18. Piraino B. Staphylococcus aureus infections in dialysis patients, focus on prevention. ASAIO J 2000; 46: S13-7.
19. Humar A, Ostromecki A, Direnfeld J et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000; 31: 1001-7.
20. Schaubel DE, Morrison HI, Fenton SS. Comparing mortality rates on CAPD/CCPD and hemodialysis. The Canadian experience: fact or fiction? Perit Dial Int 1998; 18: 478-84.
21. Gokal R, Alexander S, Ash S et al. Peritoneal catheters and exit-site practices toward optimum peritoneal access. Update Perit Dial Intern 1998; 18: 11-33.
22. Daly CD, Campbell MK, MacLeod AM et al. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 2001; 16: 341-7.
23. Ronco C, Diaz-Buxo JA. Automated peritoneal dialysis. Revisitation of the past or beginning of a new PD era? Nephron 2001; 87: 1-7.
24. Diaz-Buxo JA. Evolution of continuous flow peritoneal dialysis and the current state of the art. Semin Dial 2001; 14: 373-7.
25. Ronco C. Continuous Flow Peritoneal Dialysis. Is There a Need for it? Semin Dial 2001; 14: 395-400.
26. Alflaiw A, Vas S, Qreopoulos DG. Peritonitis in APD Patients: Diagnosis and Treatment. In: Ronco C, Amici G, Feriani M, Virga G, eds. Contributions to Nephrology Automated Peritoneal Dialisis. Basel: Karger AG, 1999; pp 213-28.
27. Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent K. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol 2001; 2: 2.
28. Jorres A. Innovative approaches to the preservation of the peritoneal membrane: From bench to bedside. Adv Ren Replace Ther 2001; 8: 164-72.
29. Vas SI. Single daily dose of aminoglycosides in the treatment of continuous ambulatory peritoneal dialysis peritonitis. Perit Dial Intern 1993; 13 (Suppl. 2): S355-6.
30. Vas S, Bargman J, Oreopoulos DG. Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Perit Dial Int 1997; 17: 91-4.
31. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27: 695-700.
32. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998; 18: 261-70.
33. Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Adv Perit Dial 2000; 16: 257-61.